Effect of Aficamten in Obstructive Hypertrophic Cardiomyopathy With Comorbidities: Obesity, Hypertension, and Diabetes: SEQUOIA-HCM Substudy. // JACC: Heart Failure. – URL: https://www.sciencedirect.com/science/article/pii/S2213177926005925?dgcid=rss_sd_all
Effect of Aficamten in Obstructive Hypertrophic Cardiomyopathy With Comorbidities: Obesity, Hypertension, and Diabetes: SEQUOIA-HCM Substudy. JACC: Heart Failure. https://www.sciencedirect.com/science/article/pii/S2213177926005925?dgcid=rss_sd_all
“Effect of Aficamten in Obstructive Hypertrophic Cardiomyopathy With Comorbidities: Obesity, Hypertension, and Diabetes: SEQUOIA-HCM Substudy.” JACC: Heart Failure.
@article{article50865,
title = {Effect of Aficamten in Obstructive Hypertrophic Cardiomyopathy With Comorbidities: Obesity, Hypertension, and Diabetes: SEQUOIA-HCM Substudy},
journal = {JACC: Heart Failure},
url = {https://www.sciencedirect.com/science/article/pii/S2213177926005925?dgcid=rss_sd_all}
}